Profile of new cases of childhood leprosy in a hospital setting

N Vara1

  • 1Assistant Professor, Department of Skin & VD, Government Medical College, Surat, Gujarat.

Indian Journal of Leprosy
|November 24, 2006
PubMed

Insights

Childhood leprosy affects 8.4% of pediatric patients, with a higher incidence in males. Most cases involved nerve damage and required multi-bacillary treatment regimens.

Area of Science:

  • Dermatology
  • Pediatrics
  • Infectious Diseases

Background:

  • Leprosy (Hansen's disease) remains a public health concern, with childhood cases indicating ongoing transmission.
  • Understanding the epidemiology and clinical presentation of leprosy in children is crucial for early diagnosis and effective management.

Purpose of the Study:

  • To determine the frequency and characteristics of childhood leprosy.
  • To analyze the types, clinical manifestations, and treatment outcomes of leprosy in pediatric patients.

Main Methods:

  • A prospective, hospital-based study was conducted.
  • 800 leprosy patients were registered, with a focus on the 67 children (aged 4-14 years) identified.
  • Clinical data, including leprosy type, lesion count, nerve involvement, and slit-skin smear results, were collected.

Main Results:

  • Children constituted 8.4% of leprosy cases (67/800), with a male-to-female ratio of 2.5:1.
  • The most common types were borderline tuberculoid (BT) leprosy (35.8%), followed by borderline borderline (BB) (25.4%) and borderline lepromatous (BL) (19.4%).
  • Over half had multiple lesions, 70.1% exhibited nerve involvement, and 46.3% had positive slit-skin smears. 29 children received paucibacillary (PB) and 38 received multidrug therapy (MB) regimens.

Conclusions:

  • Childhood leprosy represents a significant proportion of new cases, highlighting the need for continued surveillance and control efforts.
  • Early detection and appropriate treatment, including multidrug therapy for most childhood cases, are essential to prevent disability.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...